SuperFlex-3 Triple Strength by NewtonEverett — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size

75 Servings

Non-Nutrient/Non-Botanical Product Type

67% Evidence Coverage

Supplement Facts — Evidence Check

Glucosamine HCl

1500 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 1500mg

Chondroitin Sulfate

1200 mg

📊 Market median: 600.0mg (79 products) 📚 24 studies (Tier A: 0, B: 6)

This product: 1200mg

Methylsulfonylmethane

250 mg

📊 Market median: 1000.0mg (2 products)

This product: 250mg

Other Ingredients

Dicalcium Phosphate silicified Microcrystalline Cellulose Stearic Acid Cellulose Croscarmellose Sodium Vegetable Magnesium Stearate Silicon Dioxide Aqueous Coating

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: Take 2 tablets daily with a meal. Take for 4-6 weeks to see results

⚠️ Warnings & Precautions

Warning: Consult a physician before using if pregnant, nursing or on medication.

Keep out of reach of children.

Do not use this product if safety seal on the bottle is broken. Do not exceed the stated daily intake.

Contains: Shellfish (shrimp, crab).

🧪 Formulation Notes

What can SuperFlex-3 do for you? SuperFlex-3 combines the best of science and nature to support healthy joint function in active adults. 1) Glucosamine helps maintain health cartilage levels. 2) Chondroitin supports healthy joint fluid for cartilage care. 3) MSM helps support joint comfort and mobility.

Joint care formula

Glucosamine 1500 mg Chondroitin 1200 mg Plus MSM 250 mg Per serving

Strength Comfort Mobility

Additional Information

Store in a cool, dry place.

Export only

Product Details

UPC / SKU 8 18423 02772 2

DSLD Entry Date 2020-01-25

Product Type Non-Nutrient/Non-Botanical

Form Tablet or Pill

Brand NewtonEverett

DSLD ID 213120

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →